Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Cronos Australia Ltd. ( (AU:VIT) ) has shared an update.
Vitura Health Limited has notified the market that 1,931,081 performance rights have lapsed because the conditions attached to those rights were not, or could no longer be, satisfied. The cessation of these conditional securities reduces the pool of potential equity issuance, which may slightly affect future dilution outcomes for existing shareholders but does not change the company’s outstanding ordinary share capital.
The most recent analyst rating on (AU:VIT) stock is a Hold with a A$0.07 price target. To see the full list of analyst forecasts on Cronos Australia Ltd. stock, see the AU:VIT Stock Forecast page.
More about Cronos Australia Ltd.
Vitura Health Limited is an Australian-listed company in the healthcare sector, trading on the ASX under the code VIT. The company operates within the broader health and medical industry, though this announcement does not specify its particular products, services or market focus.
Average Trading Volume: 236,026
Technical Sentiment Signal: Sell
Current Market Cap: A$39.1M
Find detailed analytics on VIT stock on TipRanks’ Stock Analysis page.